# In Vivo Investigation of Novel Nano-vesicles of Salbutamol Sulphate

> **NCT03059017** · PHASE1 · COMPLETED · sponsor: **British University In Egypt** · enrollment: 20 (actual)

## Conditions studied

- Drug Effect
- Pulmonary Disease

## Interventions

- **DRUG:** Salbutamol Sulphate
- **DRUG:** Niosomes

## Key facts

- **NCT ID:** NCT03059017
- **Lead sponsor:** British University In Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-05
- **Primary completion:** 2017-02-05
- **Final completion:** 2017-02-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03059017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03059017, "In Vivo Investigation of Novel Nano-vesicles of Salbutamol Sulphate". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03059017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*